Genome wide transcription profiling is a powerful technique for studying the enormous complexity of cellular states. Moreover, when applied to disease tissue it may reveal quantitative and qualitative alterations in gene expression that give information on the context or underlying basis for the disease and may provide a new diagnostic approach. However, the data obtained from high-density microarrays is highly complex and poses considerable challenges in data mining. The data requires care in both pre-processing and the application of data mining techniques. This paper addresses the problem of dealing with microarray data that come from two known classes (Alzheimer and normal). We have applied three separate techniques to discover genes associated with Alzheimer disease (AD). The 67 genes identified in this study included a total of 17 genes that are already known to be associated with Alzheimers or other neurological diseases. This is higher than any of the previously published Alzheimer's studies. Twenty known genes, not previously associated with the disease, have been identified as well as 30 uncharacterized
Alzheimer's disease (AD) is an incurable, chronic, progressive, debilitating condition which, along with other neurodegenerative diseases, represents the largest area of unmet need in modern medicine. Progress in understanding these diseases is hampered by their complexity, but there is now renewed hope that genomics technologies, particularly gene expression profiling, can have an impact. Genome-wide expression profiling of thousands of genes provides rich datasets that can be mined to extract information on the genes that best characterize the disease state.
Gene expression profiling using microarrays is a complex task subject to many variables that can obliterate the subtle differences that exist between the normal and diseased states [13] and [33] . The best results are usually obtained when numerous samples are available and are all analyzed, in replicate, at the same time using the same lots of RNA (riboucleic acid) extraction and hybridization reagents and the same lot of microarrays. However, clinical samples from AD and normal, aged matched individuals are usually acquired in small numbers over a prolonged period of time and analyzed at different times. To date, only a few microarray studies relevant to Alzheimer's disease have been published [5] , [7] , [12] , [21] , [25] and [24] . All of these studies used small numbers of samples ranging from 1 to 6 AD patients. Significantly, there is little, and in some cases no, overlap in the genes identified between these studies and genes already known to be associated with or differentially expressed in Alzheimer's disease are seldom picked up. It is critical, therefore, to develop data processing and data mining strategies that can account for discrepancies in the data that are due to experimental variability from the true differences between the normal and disease states in small sample sets (see also [18] and [32] ).
In this paper we use a data mining strategy that can derive useful information from a small number of samples acquired and analysed at different times. In section 2 we explain the problem of gene expression profiling and in section 3 we provide details on our data preparation process. Section 4 discusses why understanding gene expression and discovering useful genes is important. Section 5 explains our data mining process and in section 6 we provide the results of this research. We conclude the paper in section 7.
The problem of gene expression profiling and data reduction
Gene expression analysis using high-density cDNA (complementary deoxyribonucleic acid) arrays presents a number of problems, both in terms of execution of the experiments and analysis of the data [10] and [40] . The primary concern is the quality of the microarrays compromised by variability in both the quality of the spotted features and imperfections in the substrate that lead to variability in the level of background. This variability can exist even within a batch of microarrays printed at the same time and there can be even more substantial variability from batch to batch. The second source of variability is in the hybridization reaction. Most microarray experiments are conducted as a competitive hybridization between a control sample (i.e. normal tissue) labelled with one fluorochrome (usually Cy3) and a test sample (i.e. disease tissue) labelled with a second fluorochrome (usually Cy5). Fluorochrome labelling is carried out using enzymes that have bias both in terms of incorporation efficiency of the different fluorochromes and in the efficiency with which they can transcribe any given sequence. The hybridization reaction, itself, is also biased in the degree to which any given probe sequence can hybridize to its cognate target and in the overall stringency of the reaction (i.e. the degree to which non-specific hybridization occurs). All of these sources of variability contribute to the generation of artifacts, some of which are remarkably reproducible.
To derive useful information from such experiments, samples must be analyzed in replicate and the data appropriately normalized and filtered to reject poor quality spots. Although improving the overall quality of the data, such pre-processing will not remove any "global" systemic biases such as those introduced by performing experiments at different institutions or at considerably different times. Methods must also be developed to assess and remove such biased data.
Experimental Procedures and Data preparation
This section includes details of our experiments and data preparation process. We briefly explain where our samples are obtained and how we performed our hybridization process. We also elaborate on the microarray data acquisition and data preprocessing steps that we have taken.
Patient samples and RNA extraction
A total of 4 clinically diagnosed AD patients and 5 normal patients of similar age were used in this study. Post mortem intervals ranged from 4 − 8 hours.
Previous studies [37] demonstrated that there is little loss of RNA integrity during this timeframe and the RNA quality is suitable for use in microarray analysis experiments. However, we cannot rule out the loss of some short halflife transcripts. All of the work was performed under a protocol approved by the National Research Council of Canada Human Ethics committee. Detailed patient information is listed in Figure 3 . Total RNA was extracted from the frontal cortex of samples of post mortem brain using the Tri Reagent (MRC Inc. Cincinnati, OH). There was no obvious RNA degradation in these samples as judged by agarose gel electrophoresis. The purity of total RNA was assessed by optical density ratios, A260/A280, which ranged from 1.8-2.0. The extractions were performed according to the manufacturer's instructions for tissue samples. Poly (A) + messenger RNA (mRNA) was then obtained from the total RNA samples using the Oligotex kit (Qiagen, Mississauga, ON Canada).
cDNA microarray hybridization
Fluorescently-labelled AD and normal patient cDNAs were hybridized to the Human 19K microarray slides obtained from The Microarray Center of the University Health Network, Toronto, Canada (http://www.microarrays.ca/). The two slide set contains 19,200 characterized and unknown human ESTs together with a number of control features. The slides are designated as Slide A and Slide B and each slide has 9,600 ESTs spotted in duplicate, organized into 32 sub-arrays of 600 spots each. The hybridizations were carried out using a common control sample created by pooling equal amounts of RNA obtained from the 4 normal patients. This sample was labeled with Cy3. The samples obtained from the 4 AD patients and the 5 normal patients (labelled with Cy5) were arrayed individually against this pooled normal control in a competitive hybridization reaction. At least three replicate hybridizations were performed for each sample. Fluorescence-labelled first strand cDNA probes were generated from 1µg of mRNA in a 40µl reaction mix, containing 1 X first strand buffer, 150 pmole AncT (5' T(20) VN 3') primer, 20 mM each of dATP, dGTP and dTTP, 2mM dCTP, 1 mM Cyanine 3-dCTP (Cy3, control samples) or Cyanine 5-dCTP (Cy5, individual normal and AD samples) and 0.4M DTT. The reaction mixture was first heated to 65
• C for 5 min and then cooled to 42
• C for another 5 min to denature the RNA and anneal the AncT primer. Reverse transcription was accomplished by adding 2µl of Superscript II reverse transcriptase (Invitrogen Life Technologies, Burlington, ON) and 1µl of RNase inhibitor (Promega, Madison, WI) and incubation at 42
• C for 2-3 h. The reaction was stopped by adding 5 ml of 50 mM EDTA and the RNA templates were hydrolyzed by adding 2µl of 10 N NaOH to the cDNA reaction, followed by an incubation at 65
• C for 20 min. The reaction was then neutralized by adding 4µl of 5 M acetic acid. Before hybridization, the Cy3 and Cy5 probes were combined and precipitated with an equal volume of isopropanol. The pellet was washed with 70% ethanol and air-dried in the dark. The labelled cDNA probe mix was then resuspened in 5µl water and combined with 80µl of DIG Easy Hyb buffer (Boehringer Manheim, Germany) containing 0.5µg/ml yeast tRNA and salmon sperm DNA. This hybridization solution was heated to 65
• C for 2 min, cooled to room temperature and injected between a paired set of the human 19K microarray slides. Hybridization was carried out in the dark at 37
• C for 18 h. After hybridization, the slides were washed three times in 1x SSC containing 10% SDS for 10 min, plus a final wash with 1x SSC alone. The slides were dried by centrifugation at 40xg in a Sigma 4K 15 centrifuge for 5 min.
Microarray data acquisition
The slides were scanned using a ScanArray 5000 confocal scanner (Packard BioScience, Meriden CT, USA) with excitation/emission wavelengths of 543 nm / 570 nm for Cy3 and 633 nm / 670 nm for Cy5, at 10 µm resolution. The resulting 16-bit grayscale image files, one for each channel, were quantitated together with QuantArray v3.0 (Packard BioScience) using an adaptive spot finding method to generate spot intensities from mean pixel values and local area background measurements were derived from a background mask (doughnut) surrounding the spot. Poor quality spots were flagged manually by the user and recorded in the output file to be used as an "ignore spot" filter. The tab delimited text data files produced were subsequently pre-processed using macros in Microsoft Excel 2000 (Microsoft Corporation, Redmond, WA).
Microarray data pre-processing
For each sample replicate there was a data file for each of the slides, A and B. Each data file contained intensity data for 19200 features (i.e. 9,600 ESTs in duplicate) measured in two channels, Ch1 and Ch2. Ch1 data represents intensity measurements from the pooled control sample and Ch2 data represents intensity measurements from the sample prepared from each individual patient who was either clinically diagnosed with AD or an age matched normal. Median subarray background values were calculated for each channel and subtracted from the respective intensity values. Spots flagged by the user during quantization (the "ignore" filter) and spots failing to meet the following criteria; intensity > 2.5-fold background and intensity > 5 th and < 98
th -percentile of all intensities for each channel, were filtered out and not used in the computation of normalization correction factors. The corrected intensity data were logged (base 2) and corrected for dye bias (normalized) using a linear-regression correction applied to the Ch2 intensities for all the spots in each subarray. This correction yielded a Ch2 versus Ch1 scatter plot with a linear regression best-fit line having slope 1 and intercept 0. Log2 ratios representing expression values for sample versus pooled control were then calculated by subtracting the Log2 Ch1 intensity from the corrected Log2 Ch2 Intensity values for each spot. Data for control spots were removed and finally the spot duplicates were averaged. The resulting data set contained 9600 Slide A and 9381 Slide B relative expression values in triplicate (or more) for the 4 AD patients and 5 age-matched controls. For this study only the data from slide A were used for gene discovery. Figure 1 shows intensity scatter (a) and M vs. A (b) plots of data from a typical microarray from a hybridization performed in this study. The raw data is shown in yellow and the processed data in blue. Normalization and filtering using the criteria described removes anomalous data and improves the fit. This is demonstrated more dramatically in the pseudo-array images of raw and processed data ( Figure 2 ). The bias caused by preferential dye incorporation is removed and the data improved considerably.
The next task was to identify the total number of missing values in the data. The distribution was not even across the samples, ranging from 7.8-37.7%. Overall, 15 .68% of all the data was missing. Using BioMiner (our data mining software introduced in Section 5) to compute statistics and generate virtual reality representations of the ratio data from each hybridization, a total of 6 samples that were poor representatives of the whole data set were identified. Based on these criteria, the 6 microarrays were rejected and the composition of the final dataset is shown in Figure 3 . This data set, called F0, was used for subsequent gene discovery experiments.
Understanding gene expression data and discovering useful genes
Gene expression data mining involves studies that combine the use of domain knowledge with data obtained from two or more classes (e.g. disease and normal) to discover genes that are associated with a particular problem. Since our data consists of two classes, those with Alzheimer's Disease and those without, the investigation is focused on using inductive and statistical techniques to identify the most informative genes amongst all the genes in the data sets. This is done through searching for patterns and relations that exist in the data. We used the following approaches to perform this search: • Pattern recognition: (see Section 5.1 for details) We arbitrarily repeated each data mining experiment 20 times to identify the most informative genes. The gene(s) identified in each experiment were then removed from the data set and the experiment was repeated until 20 experiments were completed. By doing this, we forced the algorithm to only focus on the available genes in each run. Knowing that in each run, the gene(s) with the highest information value are identified and reported, we therefore forced the algorithm to discover all important genes that could be identified in 20 runs. This approach has been used in a previous study related to gene identifications using leukemia data and has generated interesting results [11] .
• Individual dichotomization: This is a search technique performed within the scope of the information associated individually with each gene (i.e. the intensity or the ratio values). The goal is to find the best level which partitions the expression values into two sets which are maximally related (in a probabilistic sense), with two previously defined groups (in the present case, the Alzheimer and the Normal classes). Section 5.2 describes the method in detail.
• P-value and ratio thresholding: In section 5.3, a combination of twotailed one-sample and 2-sample t-tests assuming unequal variance and ratio thresholding was applied to the gene expression data to identify gene expression changes that are both statistically significant and biologically relevant.
• Virtual Reality for visualizing Databases: Relational database tables usually contain information about large collections of objects described in terms of many properties (attributes, fields). In general these attributes are composed of numeric and non-numeric information (real-valued, qualitative information, etc.), and often many of them are missing. This technique constructs a visual representation of the heterogeneous and multidimensional space of the original database objects, in the form of a virtual reality space trying to preserve as much structure of the database as possible. The result is a virtual reality environment where one can navigate and visually inspect the main features of the data. Section 5.4 describes the technique in more detail.
Gene discovery
This section includes our data mining process where we introduce our research in discovering patterns in our data and identifying genes associated with Alzheimer. We also introduce our data mining software used in these experiments. Figure 4 shows the structure of the data sets each consisting of a matrix containing p genes for n samples and an attribute vector containing labels for all samples. In each data set p=9600 and n=23. The overall goal of the research reported here was to identify from all the genes: (i) the most informative genes that are correlated with classification of AD vs normal, and (ii) models (set of rule(s)) consisting of one or more genes that contain a particular threshold to be used for accurate discrimination of AD samples from others.
Pattern recognition

The BioMiner software
The BioMiner data mining software was used for the data mining experiments reported in this paper. This software has been designed and built in house to provide support for biologists and bioinformaticians performing data mining research in functional genomics. One of the key advantages of the software is that all available forms of data pre-processing and analysis functionality are integrated into one environment. The pre-processing and data analysis modules consist of a collection of algorithms and tools to support data mining research activities in an interactive and iterative manner. Figure 5 shows the interface for the BioMiner software.
Overview of data mining experiments performed using BioMiner
The following experiments were performed on the data:
• A number of data preprocessing experiments to examine the data. These helped us to obtain a general view of the data. It was also possible to identify missing values, abnormal or interesting characteristics, such as anomalies in the data.
• Hierarchical clustering to identify the inherent class characteristics of the data.
• A set of machine learning experiments, using inductive algorithms to identify the most informative genes with an associated threshold for classification along with a measure of strength.
• Use of data visualization techniques to better investigate the overall patterns of identified genes.
Data selection for pattern recognition using BioMiner
In addition to the pre-filtered dataset, designated F0, which was generated as described in Section 3.4, a total of 3 additional data subsets were generated and used as input to the BioMiner Pattern Recognition module. These data subsets, called F1, F2 and F3, employ statistical tests designed to re- move from consideration, genes with expression profiles that are biologically meaningless (See Figure 6) . Datasets F1 and F2 were filtered using single-sample t-test p-value thresholds combined with expression ratio cut-offs on the normal patient samples only. Two different p-value/ratio threshold combinations were used: Filter F1 employed thresholds of α < 0.05 for the single sample t-test and an absolute value of the average Log2 ratio > 0.6. The settings for Filter F2 were α < 0.01 for the single sample t-test and an absolute value of the average Log2 ratio > 0.5. These filters reject data that show apparent differential expression where none is expected, i.e., genes with mean expression across normal samples significantly different from zero. Lowering the α value for the t-test decreases the number of genes filtered out, while lowering the threshold for the absolute value of the Log2 ratio increases the number of genes filtered out. Datasets F1 and F2 filtered 222 and 220 genes, respectively, from the F0 dataset. Of these, 106 were filtered by F1, 104 by F2 and 116 by both. Dataset F3 was a much more aggressive filter applied to the AD samples only. All genes with an absolute value of the average Log2 ratio < 0.5 were filtered out, removing 9519 genes from the 9600 gene dataset. This filter selects for genes with an average 1.4-fold change in gene expression or greater in AD samples.
Individual Dichotomization
The transformation of numeric attributes into discrete values (discretization) is a very useful technique, especially in relation to supervised classification and the use of induction-based methods of machine learning. Moreover, the characterization of the different attributes in terms of discrete categories simplifies the interpretation of the data and especially the relationships between single or combined attributes and the class structure. Here a simple screening algorithm was used with the purpose of finding individual relevant genes from the point of view of their ability to differentiate the class of samples having Alzheimer's disease from the normal ones. The inputs for the algorithm are: a) the values of a given attribute A (gene) for all the studied objects (in this case, the ratio between channel-2 and channel-1 for all samples, b) the classes C 1 , C 2 associated with each sample (Alzheimer vs Normal), and c) a probability threshold p T . The algorithm then proceeds as follows:
(1) construct the set of distinct values of A (call it ). That is, if O is the set of objects and A(o) is the value of the attribute for any object o ∈ O, = {δ 1 , . . . , δ p } with the following properties: 
and retain p max = max(p 1 , p 2 ). (7) if p max ≥ p T select the attribute as relevant, and discard it otherwise.
The process is repeated for all attributes describing the objects, and the resulting set of selected attributes gives an indication on how many of them (genes in this case) contain a differentiation power equal or better than the pre-set probability threshold p T . Specifically, if p T = 1 the algorithm will give a set of genes such that each of them will perfectly differentiate the corresponding classes (Alzheimer/Normal).
P-value and ratio thresholding
A standard method for determining whether two means are significantly different is the t-test. While this test, when conducted over a number of samples, can provide confidence in a mean, its application to gene expression data it may yield expression changes which are too small to be biologically meaningful. It has been suggested that simply observing a difference in the mean can serve as a proxy for more rigorous statistical approaches if the difference is large [20] , however using a large difference in means as a threshold for differential gene expression excludes many small, but significant changes. The F0 dataset was filtered using a combination of p-value and ratio thresholding according to the following criteria:
(1) Data points were rejected if the p-value from a two-tailed single-sample t-test of the Log 2 Ratio of the AD samples versus 0 was greater than 0.01. (2) Data points were rejected if the p-value from a two-tailed two-sample t-test with unequal variance of the Log 2 Ratios of the AD samples versus the normal samples was greater than 0.01. (3) Data points were rejected if the absolute value of the mean of the Log 2
Ratios of the AD samples was less than 0.41 (1.33-fold change).
Use of Virtual Reality
This is a technique for visual data mining of heterogeneous databases based on virtual reality (http://www.hybridstrategies.com), [38] and [39] . The purpose is to facilitate the process of understanding the underlying structure of single or compound databases of a general kind. The method is based on parameterized mappings between the heterogeneous spaceĤ representing the original data and the virtual reality space. They can also be constructed for unions of information systems (e.g. heterogeneous and incomplete data sets together with knowledge bases composed by decision rules), simplifying the process of discovery of interesting patterns as well as relationships between the original data and the symbolic expressions representing the structured knowledge.
A virtual reality space Ω is composed of different sets and functions in the following way: Ω =< O, G, B, m g 0 , l, g r , b, r > , where O is a relational structure (a set of objects and attributes, endowed with a set relations Γ ν defined over the objects), G is a non-empty set of geometries representing the different objects and their relationship in the visual space (an empty or invisible geometry is a possibility), B is a non-empty set of behaviors (i.e. ways in which the objects from the virtual world will express themselves: movement, response to stimulus, etc.), m is a metric space of dimension m ( ⊆ R, the reals), which will be the actual virtual reality geometric space (usually m = 3). The rest of the elements are mappings:
and r is a collection of characteristic functions for Γ
ν .
The representation of an extended information system (i.e. database)Ŝ implies the construction of another oneŜ ν in the virtual world. It requires the specification of several sets and a collection of extra mappings. There are many ways in which it can be done. A desideratum for the virtual reality heterogeneous spaceĤ ν is to keep as many properties fromŜ as possible, in particular, the similarity structure of the original data. In this sense, the idea is to maximize some metric/non-metric structure preservation criteria as in multidimensional scaling [4] and [16] , or minimize some error measure of information loss. If δ ij is a dissimilarity measure between any two objects i, j , and ξ ij is another dissimilarity measure defined on objects i ν , j ν in the virtual reality space (the images of the original objects ) , an error measure frequently used is the Sammon error = [30] . The transformation l is implicit, as no functional representations are found.
The possibilities derived from this approach are practically unlimited, since the number of different similarity, dissimilarity and distance functions definable for the different kinds of source sets is immense. Moreover, similarities and distances can be transformed into dissimilarities according to a wide variety of schemes. This provides a rich framework where appropriate measures capable of detecting interrelationships hidden in the data can be found, more suited to both its internal structure and to external criteria. The virtual reality representation of heterogeneous data sets is a technique available within the BioMiner software.
Results
This section includes results from all of our experiments. We start with our results with hierarchical clustering in which we investigated the separation between the two classes. We then continue with other results from the use of virtual reality and pattern recognition techniques to search for interesting genes among mean genes available in these experiments.
Hierarchical clustering
Since class attributes were known for each sample, we used the agglomerative hierarchical clustering algorithm with Euclidean as a distance measure and single linkage (Ward method) as options on the entire ratio data (F0) to identify the hierarchical partitioning properties among all cases. Figure 7 shows the detailed dendogram representation of the results, which illustrates how perfectly the neighboring samples are grouped together. From these results, the ratio data has only one sample (N5.1, indicated by a blue arrow) that has been incorrectly included in the first group. The red line in this figure indicates the natural separation between the two classes.
Virtual reality representation
Virtual reality representations of different data sets were constructed in order to obtain an idea of the structure of the data. For obvious reasons, it is impossible to illustrate appropriately the look, feel and immersion of a virtual reality 3D environment within the limits imposed by printed paper. Screen snapshots from different application examples are presented only to give a rough idea. The design of the virtual reality spaces was kept simple in terms of the geometries used (spheres for representing the objects and colors for representing the classes), and in particular, behaviors were excluded (objects in the virtual world are inanimate). In all cases the snapshots were simplified with regard to the information included in the corresponding virtual world to avoid information overload. In the case of F0 ratio data, each object (sample) is described by a collection of 9600 attributes (genes), therefore, each one is a vector from a 9600 dimensional space, also containing missing values. The virtual reality space (VR) is a 3D Euclidean space with the images of these objects and with non-missing values. In the first experiment, the entire F0 set was used in computing the virtual reality space. After 335 iterations, the absolute error obtained was 0.1034 (with an absolute difference = 9.9e-07). This error level indicates that the considerable non-linear dimensionality reduction which took place when going from 9600 to 3 attributes, satisfactorily retained most of the similarity structure present in the original data. The presence of a meaningful structure in the VR space characterized by a small information loss with respect to the original data (see below), clearly suggests that there is a subset of informative or relevant genes within the sample. A snapshot of the virtual worlds is shown in Figure 8 . The samples corresponding to the Alzheimer's class are colored red, and the normal ones green. In this case it is clearly seen that the samples corresponding to the Alzheimer's class appears as more homogeneous and compact (i.e. more similar to each other) than those from the normal class. Moreover, the Alzheimer class appears "wrapped" by the normal class, which is more irregular. 
Searching for genes and patterns using BioMiner software
With this understanding of the data, acquired from preprocessing, and knowing that the data was labelled, we then initiated our search for patterns through the Pattern Recognition module in BioMiner. This was done primarily to identify the most informative genes, from amongst all 9600 gene expressions. The pattern recognition module of BioMiner software provides support for various forms of supervised techniques which include discrimination and prediction, in which one can develop models from historical data to predict future cases. There are several algorithms for discrimination and prediction that are mainly from WEKA [41] and the J48 Decision Tree induction algorithm was used for these experiments. Decision trees and rule learners generate tree structures or rules directly for class assignments. A decision tree can be used to classify a case by starting at the root of the tree and moving through it until a leaf is encountered [26] . Rules are in L → R formats, in which L represents attributes-based tests and R is a class [26] . Rules could be derived from decision trees.
A number of machine learning experiments were performed to search for genes in the data. In each series of experiments, the J48 [41] rule learner was used 20 times to analyze the Ratio data and to identify the target genes from all the genes available in the data set. Figures 9-10 shows the genes discovered from all data mining experiments. The % values given for each gene indicate how accurately the gene discriminates between the two classes for that experiment. There are four groups of genes in this table that are interesting to pay attention to. Group 1 (in green) are three genes that were discovered, in all four experiments, regardless of our filtering criteria. These three genes were able to correctly discriminate 22/23 (96%) of cases (samples). Group 2 (in red) are three genes that were identified in the first three experiments. All these genes were able to discriminate between the two classes by themselves with 100% accuracy. Group 3 (in blue) are all the genes that were discovered in the first three experiments, all with 96% accuracy (22/23 samples). And finally, group 4 consists of the remainder of the genes identified. Some of these genes are also important in this gene discovery process. For example, genes 16 and 17 were identified with 96-100% accuracy in the first two runs. In fact, gene 16 (in purple) has been identified as the first (perhaps the most informative of all genes) with 100% accuracy for discrimination in the first two runs.
Following the process of identification of informative genes from the ratio data, we plotted different groups of genes for both classes and from all experiments. These plots illustrate interesting patterns between all the genes for both class 1 (AD) and 2 (normal) samples. Similarly, we used these genes to create intensity spectrum plots which also show interesting patterns. Figures 11 and 12 show plots of genes from all ratio data for both classes. Figure 13 is a spectrum plot of the top 20 genes discovered from all ratio data and Figure 14 shows the spectrum intensity pattern of the three groups of genes in Figures 9-10 (green, red and blue). In these figures, the color code is a small square for each element in the vector representing the gene. The red square represents a value greater than the center point value, and the value less than the center point is colored green. By default zero is the center point. The intensity of the color is a measure of the relative difference between values at the same side of center point. For example, the lowest values will have lightest green color and the highest ones the lightest red.
Individual Dichotomization
The Individual Dichotomization algorithm (Section 5.2) was applied to the F0 data set described in Section 3.4, with a series of probability thresholds ranging from 0.1 to 1. The dependency between the number of perfectly differentiating genes and the probability threshold is shown in Figure 15 .
In the case of a probability threshold equal to 1 (perfect classification between the Alzheimer and the Normal classes), from the 9600 genes only 4 were found having the perfect dichotomic property: (Gene #s 4,5,6 and 16 in Figures 9-10) . When only these genes are considered, the overall sample set drastically collapses to a data set of 23 objects and only 4 attributes. The virtual reality representation of this data set is shown in Figure 16 (representation error = 0.002). The Alzheimer class (red) and the Normal class (green) are displayed with a wrapping semi-transparent membrane covering all objects belonging to the corresponding class. In this virtual reality space both classes are very clearly differentiated.
When the probability threshold is lowered by allowing one misclassified sample out of the original 23 (threshold = 0.9565), then 25 genes are found relevant ( Figures 9-10 ). Lowering the threshold to allow two misclassifications (threshold = 0.9130) revealed 94 genes (data not shown).
P-value and ratio thresholding
The thresholding strategy described in section 5.3 was applied to ratio data set F0, yielding 40 genes. Of these, 10 were different clones representing just 3 genes. The cDNA microarrays used in this study contain a number of such redundancies, i.e., genes represented by cDNA from multiple different clones. Clone redundancy on the microarray can prove useful in terms of result validation. We can be more confident that a gene discovery is real when it is corroborated by independent clones that report the same expression behaviour. Genes PLP1 and HBB, were detected by 4 different clones and ADD3 was detected by 2 clones. Significantly, this represents all known clones on the microarray that target these 3 genes adding further confidence to the result. After removing clone redundancies from the list, there were 11 different genes known to be associated with AD, 12 not previously associated with the disease and 10 ESTs. Six of the AD associated genes were not discovered by either the pattern recognition or dichotomization methods used in this study. A complete list of genes discovered by this method is shown in Figures 9-10 and Figure 17 presents a summary of the gene discoveries for all the methods. Both of these tables include the redundant gene clones. The p-value and ratio cut-offs applied to the data in this strategy are somewhat arbitrary and obviously the list of genes produced by this method would be altered somewhat by choosing different thresholds. The thresholds used were selected for their potential to discover genes with significant differential expression in AD combined with a significant difference between AD and normal sample means. Retrospective analysis of the results indicated that all 15 AD-related gene discoveries would have been detected with thresholds of AD vs. 0 α < 0.0005, AD vs. normal α < 0.006 and |AD| > 0.411.
Conclusion
This paper reports the results of our data mining research in which we have searched for patterns in microarray data that come from two known classes (AD and normal). Applying data mining techniques (classical machine learning) is probably the most promising way to identify genes and their behaviour, as the samples come from classes that are known in advance. The results would therefore be more meaningful and easier to interpret, validate and apply. From the data mining point of view, a measure of success in identifying diseaseassociated, differentially expressed genes is the extent to which the algorithms identify genes that have previously been associated with disease using independent methodologies. However, from the medical point of view, success is ultimately measured in terms of a more accurate prediction and diagnosis of a disease.
In this research we applied 3 separate techniques to discover genes associated with Alzheimer's disease. Figure 17 shows the summary of the results for all of our experiments. In the first four runs (F0-F3), we used a machine learning algorithm 20 times, to identify the most informative genes through a discoverand-mask approach, in which a gene identified in a run was removed from the data set, before the next run, until all experiments were completed. This identified 20 or more of the most informative genes, as some experiments from runs F2 and F3 identified 2-3 genes. In the second technique (pVal), a statistical thresholding technique, aimed at improving the biological relevance of the results, was applied to the F0 data set. Forty genes were identified, 15 of which have been previously associated with Alzheimer's or other neurological diseases. The high yield of disease-relevant genes discovered clearly demonstrates the potential of this relatively simple method. In the third approach (DiCh), the individual dichotomizer algorithm was applied. It identified individual genes with high classification power associated with Alzheimer and normal and also the optimal ratio values differentiating these classes.
Of the 77 clones identified in this study, 24 represented 17 different genes that are already known to be associated with Alzheimer's or other neurological diseases (see Table 3 and references therein). This is higher than any of the previously published Alzheimer studies. Five of the 17 genes were represented by multiple clones. Twenty-three clones representing 20 different known genes (1 gene was represented by 4 clones), not previously associated with the disease, have been identified as well as 30 uncharacterised ESTs. The number of AD associated genes discovered using these data mining strategies is significantly higher than one would expect by chance. A literature study of 3 sets of 50 genes selected randomly from the microarray data revealed that 10 percent of the known genes had an association with AD, compared to 53 percent in the data mining study. Given the success in identifying genes already associated with AD, we can have some confidence in the involvement of the latter genes and ESTs. For example, one of the genes, identified by all of the methods, but not previously associated with AD, is dystrobrevin. Dystrobrevin is a dystrophin-associated protein found in dystrophin-associated protein complexes in the brain [1] . Given that one third of Duschenne muscular dystrophy patients, a disease caused by mutations in the dystrophin gene, have a mild dementia, it is possible that altered expression of dystrobrevin could be related to dementia of the Alzheimer type. Similarly, there is a high probability that proprotein convertase inhibitor (PSK1N) could be AD-associated given the role of proprotein convertase in β-amyloid processing [34] . The biological significance of the AD-associated genes found in this paper will be discussed further in a subsequent publication.
